Sign in

Vir Biotechnology, Inc.

Income Statement - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.07 0.07 0.09 1.62 1.10 0.08 0.00 0.00 0.00
Cost of revenue 0.01 0.48 0.57 0.62 0.51 0.30 0.14 0.10 0.06
Gross profit 0.06 -0.40 -0.49 0.99 0.58 0.08 0.00 -0.10 -0.06
Total operating expenses + 0.52 0.18 0.20 0.16 0.16 0.37 0.18 0.12 0.08
Operating income -0.47 -0.59 -0.68 0.83 0.42 -0.30 -0.18 -0.12 -0.08
Non-operating income (net) 0.03 0.06 0.06 -0.08 0.13 0.00 0.00 0.00 0.00
Income before tax -0.44 -0.52 -0.63 0.75 0.55 -0.30 -0.17 -0.12 -0.08
Income tax expense 0.00 0.00 -0.01 0.24 0.02 0.00 0.00 0.00 -0.01
Net income -0.44 -0.52 -0.62 0.52 0.53 -0.30 -0.17 -0.12 -0.07
Show Quarterly Income Statement

Income Statement - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.00 0.06 0.00 0.00 0.00 0.01 0.00 0.00 0.06 0.02 0.00 0.00 0.06 0.05 0.37 -0.04 1.23 0.81 0.10 0.18 0.00 0.00 0.00 0.07 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 -0.37 0.15 0.10 0.12 0.09 0.20 0.11 0.10 0.11 0.15 0.17 0.16 0.16 0.14 0.14 0.18 0.19 0.11 0.09 0.13 0.00 0.07 0.08 0.06 0.05 0.04 0.03 0.03 0.02 0.03 0.02 0.02
Gross profit 0.00 0.43 -0.15 -0.10 -0.11 -0.08 -0.19 -0.10 -0.04 -0.09 -0.14 -0.16 -0.10 -0.11 0.24 -0.18 1.05 0.63 0.00 0.09 0.00 0.00 0.00 0.07 -0.05 -0.05 -0.04 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02
Total operating expenses + 0.13 0.47 0.02 0.02 0.02 0.04 0.04 0.06 0.04 0.05 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.06 0.05 0.03 0.16 0.11 0.09 0.10 0.02 0.01 0.05 0.04 0.03 0.03 0.03 0.01 0.01
Operating income -0.13 -0.04 -0.17 -0.12 -0.14 -0.12 -0.23 -0.16 -0.08 -0.14 -0.19 -0.22 -0.14 -0.15 0.19 -0.23 1.01 0.57 -0.05 0.06 -0.16 -0.11 -0.09 -0.03 -0.07 -0.06 -0.05 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03
Non-operating income (net) 0.01 -0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 0.02 -0.01 -0.09 -0.03 0.16 0.00 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.13 -0.04 -0.16 -0.11 -0.12 -0.10 -0.21 -0.14 -0.07 -0.12 -0.17 -0.20 -0.14 -0.15 0.22 -0.23 0.92 0.55 0.11 0.06 -0.17 -0.11 -0.08 -0.03 -0.08 -0.06 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 0.04 -0.16 0.40 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.13 -0.04 -0.16 -0.11 -0.12 -0.10 -0.21 -0.14 -0.07 -0.12 -0.16 -0.19 -0.14 -0.10 0.18 -0.08 0.52 0.53 0.11 0.06 -0.17 -0.11 -0.08 -0.03 -0.08 -0.06 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03
5 days ago

Balance Sheet - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.46 0.91 1.52 2.40 0.71 0.74 0.38 0.10 0.19
Accounts receivable, net 0.00 0.01 0.01 0.03 0.77 0.00
Inventories 0.01 0.00 0.00
Other current assets 0.05 0.14 0.07 0.12 0.08 0.04 0.01 0.02 0.00
Total current assets 0.51 1.04 1.59 2.52 1.56 0.77 0.40 0.12 0.19
Total non-current assets + 0.49 0.36 0.33 0.28 0.39 0.15 0.11 0.07 0.06
Total assets 1.00 1.40 1.92 2.80 1.95 0.92 0.51 0.19 0.25
Total current liabilities + 0.09 0.12 0.18 0.51 0.34 0.10 0.06 0.04 0.01
Total non-current liabilities + 0.14 0.13 0.15 0.21 0.18 0.10 0.03 0.33 0.31
Total liabilities 0.24 0.25 0.33 0.72 0.52 0.20 0.09 0.37 0.32
Total stockholders' equity + 0.77 1.15 1.59 2.08 1.43 0.72 0.42 -0.18 -0.07
Common shares outstanding 139 136 134 135 133 119 108 97 7
Show Quarterly Balance Sheet

Balance Sheet - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.47 0.46 0.51 0.61 0.80 0.91 0.91 1.15 1.15 1.52 1.70 1.85 2.25 2.40 2.35 2.20 1.26 0.71 0.94 0.83 0.73 0.74 0.83 0.55 0.36 0.38 0.32 0.36 0.10 0.10 0.00 0.00 0.19
Accounts receivable, net 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02 0.03 0.01 0.01 1.22 0.77 0.09 0.00 0.23 0.00 0.00 0.00 0.00 0.00
Inventories -0.01 0.00 0.01 0.00 -0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Other current assets 0.05 0.05 0.04 0.13 0.13 0.13 0.13 0.05 0.06 0.07 0.07 0.10 0.11 0.12 0.07 0.09 0.08 0.08 0.03 0.04 0.04 0.04 0.02 0.03 0.02 0.01 0.01 0.02 0.01 0.02 0.00
Total current assets 0.52 0.51 0.55 0.74 0.93 1.04 1.05 1.21 1.21 1.59 1.77 1.95 2.36 2.52 2.41 2.29 2.57 1.56 1.07 0.86 0.99 0.77 0.85 0.58 0.38 0.40 0.34 0.38 0.10 0.12 0.19
Total non-current assets + 0.50 0.49 0.47 0.46 0.38 0.36 0.45 0.46 0.58 0.33 0.28 0.30 0.31 0.28 0.28 0.33 0.32 0.39 0.14 0.20 0.14 0.15 0.09 0.09 0.10 0.11 0.08 0.08 -0.10 0.07 -0.19
Total assets 1.03 1.00 1.02 1.19 1.31 1.40 1.50 1.67 1.79 1.92 2.04 2.24 2.67 2.80 2.70 2.62 2.89 1.95 1.21 1.06 1.14 0.92 0.94 0.67 0.48 0.51 0.42 0.46 0.46 0.19 0.00
Total current liabilities + 0.07 0.09 0.08 0.11 0.14 0.12 0.12 0.10 0.09 0.18 0.17 0.23 0.49 0.51 0.31 0.48 0.70 0.34 0.23 0.15 0.36 0.10 0.08 0.05 0.06 0.06 0.04 0.04 0.04 0.04 0.00
Total non-current liabilities + 0.14 0.14 0.15 0.14 0.13 0.13 0.14 0.14 0.15 0.15 0.20 0.21 0.21 0.21 0.24 0.19 0.18 0.18 0.10 0.17 0.12 0.10 0.05 0.05 0.04 0.03 0.66 0.01 0.00 0.33 0.00
Total liabilities 0.21 0.24 0.22 0.25 0.26 0.25 0.26 0.24 0.25 0.33 0.37 0.43 0.70 0.72 0.55 0.67 0.89 0.52 0.33 0.32 0.48 0.20 0.13 0.11 0.10 0.09 0.70 0.06 0.06 0.37 0.00
Total stockholders' equity + 0.81 0.77 0.80 0.95 1.04 1.15 1.24 1.43 1.55 1.59 1.68 1.81 1.97 2.08 2.15 1.95 2.00 1.43 0.88 0.74 0.65 0.72 0.81 0.56 0.38 0.42 -0.28 0.40 0.13 -0.18 0.22
Common shares outstanding 147 139 139 138 137 137 137 136 135 135 134 134 134 133 135 132 135 134 134 134 128 127 126 115 108 92 109 109 97 97 97 7 7
5 days ago

Cash Flow - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + -0.39 -0.45 -0.78 1.66 -0.05 -0.19 -0.13 -0.09 -0.07
Cash flow from investing + 0.31 0.50 0.16 -1.19 -0.14 -0.01 -0.26 -0.06 -0.03
Cash flow from financing + 0.00 0.00 0.01 0.03 0.10 0.53 0.45 0.02 0.27
Change in cash -0.08 0.06 -0.61 0.50 -0.09 0.33 0.06 -0.13 0.17
Change in exchange rate 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.13 -0.03 -0.17 -0.12 -0.08 -0.09 -0.17 -0.08 -0.11 -0.11 -0.16 -0.39 -0.13 0.04 0.12 0.96 0.55 0.01 -0.11 0.14 -0.09 -0.08 -0.05 -0.01 -0.05 -0.04 -0.04 -0.02 -0.03 -0.03 -0.03 -0.01 -0.01
Cash flow from investing + 0.01 0.09 0.04 0.06 0.13 0.14 0.12 0.21 0.03 -0.10 -0.06 0.23 0.10 -0.15 -0.66 -0.27 -0.11 -0.38 0.07 0.08 0.09 0.06 -0.19 0.01 0.10 -0.07 0.05 0.04 -0.27 0.02 0.02 -0.05 -0.05
Cash flow from financing + 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.09 0.00 0.32 0.21 0.00 0.13 0.00 0.00 0.32 0.01 0.00 0.01 0.01
Change in cash 0.04 0.06 -0.13 -0.06 0.05 0.05 -0.05 0.14 -0.08 -0.21 -0.21 -0.16 -0.03 -0.12 -0.54 0.69 0.47 -0.36 -0.03 0.22 0.09 -0.02 0.09 0.21 0.06 0.02 0.01 0.02 0.01 0.00 -0.01 -0.06 -0.06
Change in exchange rate 0.00 0.00 0.00 0.00
5 days ago

Vir Biotechnology, Inc. (VIR) - Current Accounts Payable

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Total Current Liabilities

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Total Liabilities

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Other Current Assets

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Short Term Investments

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Long Term Investments

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Goodwill

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Intangible Assets Excluding Goodwill

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Intangible Assets

1Y 2Y 5Y Max
10 days ago

Vir Biotechnology, Inc. (VIR) - Total Non Current Assets

1Y 2Y 5Y Max
10 days ago